Geometry Dash APK Hill Climb Racing APK
15.6 F
New York
Friday, January 21, 2022

Moleculin Biotech Inc (NASDAQ:MBRX) More Than Doubled On Potential Covid-19 Treatment

Must read

Humbl Inc (OTCMKTS:TSNPD) Bounces Back and Lands On The Radar

Over the course of the past months, Humbl Inc (OTCMKTS:TSNPD) stock has managed to record massive gains and much of that has...

Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Looks to Maintain Critical Momentum

Stocks that make massive gains over a reasonable period of time cannot hope to maintain them forever. At some point, a correction...

Green Thumb Industries Inc (OTCMKTS:GTBIF) Trades Near All-Time High: What Next?

After having been in the dumps for more than a year, the cannabis sector has managed to make a remarkable comeback. Investors...

VIVO Cannabis Inc (OTCMKTS:VVCIF) Stock Turns Volatile: Uptrend in Jeopardy

Anyone watching the market knows the cannabis sector has been booming again. Since the start of the year, the cannabis sector has...

The coronavirus crisis may have unleashed chaos in the markets, but it has also become an opportunity for pharmaceutical and biotech firms. Over the past weeks, the stocks of many such firms have soared on the back of their work related to developing medicines, diagnostics, or vaccines to tackle the coronavirus.

Major Trigger

Late last week, Moleculin Biotech Inc (NASDAQ:MBRX) emerged as the latest company to enjoy such a bump in its stock price after it made an announcement with regards to its product 2-deoxy-D-glucose or 2-DG. The company announced that in vitro testing, it emerged that the medicine was successful in reducing the virus completely.

That is a significant development for Moleculin, and investors reacted positively to the news as well. The company’s stock rallied by as much as 134% in Thursday’s trading to hit $1.32, up from $0.57, and it remains to be seen if it can hold those gains. The research was conducted by experts at the University of Frankfurt, and the findings were published in the magazine named NatureResearch back on March 11.

The Chief Executive Officer of the company, Walter Kemp, stated that it is an ‘unexpected breakthrough’ for the company. However, he went on to add that this was exactly the sort of breakthrough that Moleculin was looking for.

While the breakthrough is significant for Moleculin, it is also important to note that the United States Food and Drug Administration has actually cleared the way for fast development of coronavirus related therapies. Hence, it could prove to be a massive boost for the company in the long run. The Chief Medical Officer of the company, Dr. Sandra Silberman, said as much.

Silberman stated that the company is now going to move along the clinical trials of the product on an expedited basis. That being said, the rise in the stock price indicates that the market is quite excited about Moleculin, and investors could also consider keeping an eye on things.

Latest article

iQSTEL Inc (OTCMKTS:IQST) Stock Makes a Big Move: Jumps 45% In a Week

In the past week, iQSTEL Inc (OTCMKTS: IQST) has emerged as a point of focus among a large number of investors and...

HUMBL Inc (OTCMKTS:HMBL) Stock Sees Big Bounce After Recent Slump

Since the beginning of 2021, HUMBL Inc (OTCMKTS:HMBL) had been one of the major movers from among penny stocks and had come into...

Dividend Stocks to Buy Now

A classic mistake that investors make when looking for dividend stocks is to just go for the biggest dividend yield. It makes...

88 Energy Ltd (OTCMKTS:EEENF) Stock Surges 40% But Can’t Hold Gains

The oil and gas company 88 Energy Ltd (OTCMKTS:EEENF) seems to have come back on to the radars of investors over the...

Net Savings Link Inc (OTCMKTS:NSAV) Stock is Getting Pummeled Again

Nowadays there are plenty of options for investors when it comes to making investments in the cryptocurrency and...
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet. Affordable best sms verification service